MTOR and non-small cell lung carcinoma: Broutin et al. investigated the dependence of MEK and mTOR inhibition in a panel of KRAS mutant and KRAS wildtype NSCLC cell lines and showed for the first time that inhibition of mTOR but not MEK contributes to the majority of the growth inhibition in this combination [122].